Ultacan
Product Images NDC 52120-200

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ultacan (NDC 52120-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hansamed, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Articaine HCl Formula Structure (85dfc4ff E676 4dac 9dd8 63c15af9842c 01)

Chemical structure diagram showing the molecular formula of the active ingredient in Ultacan, including a thiazole ring and associated side chains, indicating it is a hydrochloride salt.*

FDA Label Image

Epinephrine Bitartrate Formula Structure (85dfc4ff E676 4dac 9dd8 63c15af9842c 02)

Chemical structure diagram showing two compounds separated by a multiplication sign, likely representing the active ingredient and a counter-ion or complex in Ultacan by HANSAmed, Inc. The top structure includes a benzene ring with hydroxyl groups and an ethanolamine side chain, while the lower structure depicts an organic acid with multiple hydroxyl and carboxyl groups.*

FDA Label Image

Principal Display Panel (1:200,000)

Ultacan (Articaine hydrochloride 4% and epinephrine 1:200,000 injection, USP) packaging label for 50 single-use cartridges of 1.7 mL each. The product is sterile and intended for infiltration and nerve block anesthesia, distributed by HANSAmed, Inc.*

FDA Label Image

Principal Display Panel (1:100,000)

Ultacan forte injection label showing active ingredients Articaine hydrochloride 4% and epinephrine 1:100,000. The label indicates it is sterile for infiltration and nerve block anesthesia and intended for intraoral submucosal injection. Contains 50 single-use cartridges of 1.7 mL each, distributed by HANSAmed, Inc.*

FDA Label Image

Principal Display Panels (1:200,000 Side)

Drug facts text panels for Ultacan injection showing components and usage instructions. Ultacan contains Articaine hydrochloride 4% and epinephrine 1:200,000. Panel details composition per mL, including articaine hydrochloride 40 mg and epinephrine bitartrate 0.009 mg, along with excipients. Directions warn against intravenous injection and advise professional dental use only, with storage and handling precautions. Labels state manufacturer Sanofi-Aventis Deutschland GmbH for HANSAmed Inc.*

FDA Label Image

Principal Display Panels (1:100,000 Side)

Drug label panels for Ultacan forte (Articaine hydrochloride 4% and epinephrine 1:100,000 injection, USP) show ingredient concentrations, including 40 mg articaine hydrochloride and 0.018 mg epinephrine bitartrate per mL. Directions advise professional dental use, avoiding intravenous injection, light protection, package integrity, and warnings against freezing and discoloration. Manufacturer information identifies Sanofi-Aventis Deutschland GmbH for HANSAmed Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.